PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression

Dai Horiuchi*, Roman Camarda, Alicia Y. Zhou, Christina Yau, Olga Momcilovic, Sanjeev Balakrishnan, Alexandra N. Corella, Henok Eyob, Kai Kessenbrock, Devon A. Lawson, Lindsey A. Marsh, Brittany N. Anderton, Julia Rohrberg, Ratika Kunder, Alexey V. Bazarov, Paul Yaswen, Michael T. McManus, Hope S. Rugo, Zena Werb, Andrei Goga

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint Dive into the research topics of 'PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds